Comunicati.net - Comunicati pubblicati - Automotive Market Research Reports Comunicati.net - Comunicati pubblicati - Automotive Market Research Reports Tue, 09 Mar 2021 02:55:23 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/utenti/26559/1 Advancements in technology for the development of new UV infection control devices in this region Thu, 04 Mar 2021 12:50:57 +0100 http://comunicati.net/comunicati/aziende/fiere/693400.html http://comunicati.net/comunicati/aziende/fiere/693400.html Automotive Market Research Reports Automotive Market Research Reports Rise in government focus on infection control programs, increase in the prevalence of hospital-acquired infections, and rise in adoption of technology advanced UV equipment fuel the growth of the global UV infection control market. On the other hand, high cost of UV infection control devices and stringent government regulation restrain the growth to some extent. However, high growth prospects in emerging markets is expected to create lucrative opportunities in the near future.

The global UV Infection Control Devices Industry garnered $317.42 million in 2018, and is expected to reach $524.84 million by 2026, growing at a CAGR of 6.5% from 2019 to 2026.

Image for post

The end user segment to dominate during the estimated period-

Based on end user, the hospital segment held the major share in 2018, generating nearly half of the global UV infection control market. The segment is anticipated to maintain its dominance throughout the forecast period. Moreover, the same segment would showcase the fastest CAGR of 6.8% during the study period. This is attributed to the fact that hospitals receive different types of patients that require surgeries, which leads to increase the adoption of UV infection control devices and therefore drives the growth of the segment.

Focus of governments on infection control programs, surge in prevalence of hospital acquired infections (HAI), and increase in adoption of technologically advanced UV equipment drive the growth of the global UV infection control devices market. However, high costs and strict government regulations hinder the market growth. On the other hand, untapped potential in emerging countries create new opportunities in coming years.

The demand for UV infection control devices is on a rise, owing to increase in government focus on infection control programs and surge in prevalence of hospital acquired infections (HAI).

Surge in government focus on infection control programs and increase in the prevalence of hospital acquired infections (HAI) are the major factors that contribute to the growth of the UV infection control devices market. Furthermore, rise in adoption of technologically advanced UV equipment further supplement the growth of the market. However, high cost of UV infection control devices and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the UV infection control devices market growth.

Frontrunners in the industry-

  • CVS Health Corporation
  • DocMorris
  • Express Scripts Holding Company
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Stores Inc.
  • Apollo Pharmacy.

North America to retain its dominance in terms of revenue-

Based on geography, North America accounted for more than two-fifths of the global UV infection control market revenue in 2026, and is projected to maintain the lion’s share from 2019 to 2026. The region is anticipated to maintain its dominance throughout the forecast period. This is attributed to the rise in the number of cases of HAIs and presence of key players lead to easy availability of these devices in this region. On the other hand, the region across Asia-Pacific is expected to manifest the fastest CAGR of 8.1% from 2020 to 2027. This is due to the improvements in health standards, surge in disposable incomes, and advancements in technology for the development of new UV infection control devices in this region.

Read More: https://www.alliedmarketresearch.com/uv-infection-control-devices-market-A06107

]]>
Prescription segment to manifest the fastest growth through 2026 Thu, 04 Mar 2021 12:37:20 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/693394.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/693394.html Automotive Market Research Reports Automotive Market Research Reports Rise in prevalence of psoriasis & psoriatic arthritis disease, increase in number of pipeline drugs, and surge in government expenditure on healthcare have boosted the growth of the global psoriatic arthritis treatment market. However, poor demand in under-developed countries hamper the market. On the contrary, growth potential in the emerging market is expected to create lucrative opportunities in the near future.

Global psoriatic arthritis treatment industry was pegged at $7.86 billion in 2018, and is expected to reach $13.74 billion by 2026, growing at a CAGR of 7.2% from 2019 to 2026.

Image for post

Prescription segment to manifest the fastest growth through 2026

The prescription segment is expected to manifest the fastest CAGR of 7.4% during the forecast period, owing to rise in demand for prescription drugs during the treatment of psoriatic arthritis without causing side effects. Moreover, the segment dominated the global psoriatic arthritis treatment market in 2018, accounting for more than four-fifths of the market. The report also analyzes the OTC segment.

Biologics segment dominated the market

By drug type, the biologics segment held the largest share in 2018, contributing to more than three-fifths of the global psoriatic arthritis treatment market. Moreover, the segment is expected to register the fastest CAGR of 7.9% during the forecast period. This is due to surge in patient awareness toward the availability of DMARDs drugs for psoriatic arthritis treatment, rise in prevalence of psoriatic arthritis, presence of biologics &biosimilars, and increase in healthcare expenditure in developed regions. The report includes an in-depth analysis other segments such as NSAIDs, DMARDs, and other.

Major market player

  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Eli Lilly And Company
  • Celgene Corporation
  • Merck & Co Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • UCB S.A.

North America held the largest share

The global psoriatic arthritis treatment market across North America held the largest share in 2018, contributing for more than half of the market, owing to presence of key players in the region. Moreover, rise in prevalence of psoriatic arthritis disease, surge in demand for psoriatic arthritis treatment drugs, presence of advanced healthcare facilities coupled with trained medical professionals, and surge in number of R&D centers significantly contribute toward the growth of the North America market.

Read More: https://www.alliedmarketresearch.com/psoriatic-arthritis-treatment-market-A05951Jonepoul

]]>
North America accounted for the majority of the market share in 2018 and is anticipated to continue this trend during the forecast period. Wed, 03 Mar 2021 12:35:09 +0100 http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/693077.html http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/693077.html Automotive Market Research Reports Automotive Market Research Reports Significant rise in surgical procedures, and surge in technological developments in surgical lights drive the growth of the global surgical lights market. On the other hand, high cost of LED lights restrains the growth to some extent. However, various growth opportunities in emerging economies are expected to create a number of opportunities in the industry.

The global surgical lights industry was estimated at $2.71 billion in 2018, and is projected to garner $3.83 billion by 2026, registering a CAGR of 4.5% from 2019 to 2026.

Image for post

The halogen segment to lead the trail till 2026-

Based on type, the halogen segment accounted for more than half of the global surgical lights market share in 2018, and is expected to rule the roost by the end of 2026. This is due to its wide usage in the hospital and ambulatory settings. On the other hand, the LED segment is projected to register the fastest CAGR of 4.6% during 2019–2026.

The major factors that drive the surgical lights market include increase in number of hospitals across the globe, surge in disorders, rise in surgical procedures, and increase in global geriatric population. Further, rise in product availability, significant surge in demand for well-equipped surgical lights for better & enhanced visibility and accessibility of healthcare facilities, and improvement of healthcare infrastructure in the developed economies boost the growth of the surgical lights market. However, high cost of LED & CFL lights and implications caused from their vigorous usage are the factors anticipated to hamper the market growth. On the contrary, technological advancements in these lights and surge in awareness toward patient care are expected to create lucrative opportunities for the market expansion.

North America to maintain its top status in terms of revenue-

Based on geography, North America held the major share in 2018, garnering more than one-third of the global surgical lights market, owing to rise in prevalence of disorders such as cardiac diseases and gynecological diseases, among others. At the same time, the Asia-Pacific region would register the fastest CAGR of 5.3% during the study period. This is due surge in demand for healthcare infrastructure, rise in number of hospitals in emerging countries, increase in healthcare reforms, and increase in technological advancements in the field of healthcare.

Leading players in the market-

  • CV Medical
  • Getinge AB
  • A-dec Inc
  • Herbert Waldmann GmbH & Co
  • Hill-Rom Services
  • BihlerMED
  • S.I.M.E.O.N
  • Medical GmbH & Co. KG
  • Steris plc
  • Skytron

Read More: https://www.alliedmarketresearch.com/surgical-lights-market-A06076

]]>
Syringes Market Expected to Reach $32.39 Billion by 2027 Tue, 02 Mar 2021 16:15:28 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/692844.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/692844.html Automotive Market Research Reports Automotive Market Research Reports Upsurge in incidence of needle stick injuries, rise in awareness about smart syringes, and high-end technological advancements fuel the growth of the global syringes market. On the other hand, high cost and unaffordability of safety syringes and alternative modes of drug delivery impede the growth to some extent. However, increase in need for safety syringes in emerging economies is expected to create lucrative opportunities in the industry.

The global syringes market size was estimated at $15.34 billion in 2019, and is expected to hit $32.39 billion by 2027, registering a CAGR of 9.6% from 2020 to 2027.

Image for post

The specialized syringes segment to dominate by 2027-

Based on product, the specialized syringes segment accounted for more than two-thirds of the global syringes market share in 2019, and is projected to maintain the lion’s share by the end of 2027. The same segment would also register the fastest CAGR of 10.0% from 2020 to 2027. Surge in use of disposable syringes and rise in demand for injectable drugs drive the growth of the segment.

Rise in incidence of needle stick injuries, increase in awareness about smart syringes, and high-end technological advancements drive the growth of the global syringes market. However, high cost and unaffordability of safety syringes and alternative modes of drug delivery hider the growth to some extent. Nevertheless, rise in need for safety syringes in emerging countries is anticipated to usher a plethora of opportunities for the market players.

Frontrunners in the industry-

  • B. Braun Melsungen AG
  • Becton
  • Dickinson and Company
  • Cardinal Health Inc
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Medline Industries, Inc
  • Nipro Corporation (Nipro Medical Corporation)
  • Retractable Technologies, Inc
  • Smith’s Group Plc
  • Terumo Corporation (Terumo Medical Corporation)

North America had the major share in 2019-

Based on geography, North America held the major share in 2019, garnering more than two-fifths of the global syringes market. This is due to increase in demand for advanced syringes, availability of well-developed healthcare infrastructure, and presence of major giants in the region. Simultaneously, the market across Asia-Pacific would exhibit the fastest CAGR of 10.8% from 2020 to 2027, owing to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.

Click Here @ https://www.alliedmarketresearch.com/syringes-market-A07514

]]>
Advanced Wound Care Market Overview Fri, 26 Feb 2021 09:54:47 +0100 http://comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/691967.html http://comunicati.net/comunicati/istituzioni/comuni/friuli_venezia_giulia/691967.html Automotive Market Research Reports Automotive Market Research Reports Surge in geriatric population, increase in incidences of diabetes, obesity and chronic conditions, and high-end technological advancements to deal with complex wounds fuel the growth of the global advanced wound care market. On the other hand, high cost of advanced wound care products impedes the growth to some extent. Nevertheless, untapped opportunities in developing economies is expected to create a number of opportunities for the key players in the industry.

The advanced wound care market size was valued at $9,255.70 million in 2019, and is estimated to reach at $15,305.94 million by 2027, registering a CAGR of 11.6% from 2020 to 2027.

Image for post

Growth of the global advanced wound care market is attributed to increase in geriatric population and increase in incidences of diabetes, ulcer, obesity, and chronic conditions. Furthermore, surge in awareness related to advanced wound care applications and advantages are some of the factors that contribute to the growth of the market.

The chronic wounds segment to remain lucrative during the estimated period-

Based on application, the chronic wounds segment contributed to more than two-thirds of the global advanced wound care market in 2018, and is anticipated to dominate during 2019–2026. The same segment is also projected to register the fastest CAGR of 6.7% by 2026. Various methods are now available to treat chronic wounds, including, debridement, moist wound healing, vacuum-assisted closure, oxygenation, warming etc., which has driven the growth of the segment.

The major factors that boost the growth of the global advanced wound care market are rise in adoption of evidence-based treatments for chronic wounds and rapid increase in geriatric population. In addition, advanced wound care products promote faster wound healing, and hence are gaining an edge over traditional wound care and closure products, which significantly contributes toward the growth of the market.

Key market players

  • Adynxx, Inc.
  • 3M (Acelity Inc.)
  • Smith & Nephew Plc.
  • Coloplast A/S
  • ConvaTec Group Plc.
  • AB (Mölnlycke Health Care AB)
  • Essity AB (BSN Medical GmbH)
  • Medtronic Plc.
  • Integra Lifesciences (Derma sciences)
  • Investor Johnson & Johnson
  • Medline Industries, Inc.
  • B Braun Melsungen AG
  • Organogenesis Holdings Inc.

The chronic wounds segment to remain lucrative during the estimated period-

Based on application, the chronic wounds segment contributed to more than two-thirds of the global advanced wound care market in 2018, and is anticipated to dominate during 2019–2026. The same segment is also projected to register the fastest CAGR of 6.7% by 2026. Various methods are now available to treat chronic wounds, including, debridement, moist wound healing, vacuum-assisted closure, oxygenation, warming etc., which has driven the growth of the segment.

Click Here@ https://www.alliedmarketresearch.com/Advanced-Wound-Care-marketLisa

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked

]]>
Rise in importance of biological and targeted drug therapies, technological developments Fri, 26 Feb 2021 09:48:26 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/691964.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/691964.html Automotive Market Research Reports Automotive Market Research Reports The growth of the global cancer biomarkers market is due to surge in adoption of cancer biomarkers primarily for prognostics and diagnostics applications across the global.

Surge in number of patients suffering from various types of cancers such as prostate, breast, and lung cancer, rise in number of clinical trials, and high accuracy & reliability drive the growth of the global cancer biomarkers market. However, high cost associated with drug development and fatal effects of cancer drug therapy restrain the market growth. Furthermore, technological advancements in cancer therapy and focus on advanced treatment protocols are expected to create new growth opportunities for the market players.

Cancer Biomarkers Marketgenerated $10.94 billion in 2019, and is estimated to reach $26.97 billion by 2027, potraying a CAGR of 11.8% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios.

Image for post

Based on biomolecule, the genetic biomarkers segment accounted for the largest share in 2019, holding nearly half of the total share, and is expected to maintain the largest share throughout the forecast period. However, glyco-biomarkers segment is expected to register the highest CAGR of 12.5% from 2020 to 2027.

The global cancer biomarker market has witnessed an unprecedented growth in past few years. Rise in importance of biological and targeted drug therapies, technological developments, and surgein prevalence of various types of cancers contribute toward the cancer biomarker market growth. Moreover, cancer biomarkers are commonly used, as they are more reliable and accurate than other diagnostic techniques. The market is expected to grow at a significant pace during the forecast period.

The market is estimated to gain momentum in developing regions of Asia-Pacific and Latin America. Factors such as rapid urbanization, increase in geriatric population and undiagnosed patients, surge in the adoption of remote patient monitoring devices, rise in disposable income, and surge inawareness about the benefits of cancer biomarkers are expected to boost the market growth in these regions.

Leading market players analyzed in the research include Bio-Rad Laboratories, Abbott Laboratories, Exact Sciences Corporation, Bristol-Myers Squibb Company, Merck KGaA, F.Hoffmann-La Roche Ltd., Qiagen N.V., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and Siemens AG.

Read More: https://www.alliedmarketresearch.com/cancer-biomarkers-market

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

]]>
High prevalence of chronic diseases and rise in geriatric population drive the growth of the global powered surgical instrument market. Thu, 25 Feb 2021 11:42:00 +0100 http://comunicati.net/comunicati/istituzioni/comuni/basilicata/691574.html http://comunicati.net/comunicati/istituzioni/comuni/basilicata/691574.html Automotive Market Research Reports Automotive Market Research Reports High prevalence of chronic diseases and rise in geriatric population drive the growth of the global powered surgical instrument market. However, inadequate quality assurance and lack of proper sterilization practices hamper the market growth. On the contrary, increasing healthcare expenditure is expected to create lucrative opportunities for the market players in the coming years.

Rising demand of non-invasive & minimally invasive surgery and growing geriatric population play a major role in the growth of the powered surgical instrument market. Furthermore, rise in medical tourism in developing countries is expected to boost the market growth in the coming years.

The global powered surgical instrument market generated $1,943 million in 2017 and is projected to reach $2,731 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. The handpieces segment accounted for more than three-fifth of the total market share in 2017.

Image for post

Plastic surgery segment to manifest rapid growth by 2025

The plastic surgery segment is estimated to register the fastest CAGR of 6.2% from 2017 to 2023, owing to the growing demand for cosmetic surgeries, increasing incidence of cancer, and growing age-related surgeries across the globe. However, the orthopedic surgery segment accounted the largest share, contributing about 21% share of the market, owing to increased demand for minimally invasive surgery in orthopedics and rise in geriatric population. The other segments analyzed in the report include neurosurgery, ENT surgery, cardiovascular surgery, cardiothoracic surgery, and others.North America governs the market in 2017

North America held the largest share in the global powered surgical instrument market, garnering about half of the total revenue in 2017, owing to highly sophisticated healthcare infrastructure and high adoption rate of technologically advanced surgical tools in the region. However, Asia-Pacific region is expected to portray the fastest CAGR of 5.4% during the forecast period, owing to high prevalence of chronic diseases and rise in demand of minimally invasive surgery. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).

Key Findings of thePowered Surgical Instrument Market:

  • Based on power source, the battery-powered instruments segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 4.9% from 2018 to 2025.
  • Depending on application, the cardiovascular surgery segment is expected to exhibit the highest CAGR during the forecast period.
  • By product, the handpieces segment was the major revenue contributor in 2017 and is anticipated to continue this trend during the forecast period.
  • The U.S. generated the highest revenue in the global powered surgical instrument market in 2017, accounting for almost two-fifth of the global market in 2017.
  • Asia-Pacific is estimated to grow at a CAGR of 5.4% during the forecast period.

Torchbearers of the market

The key players analyzed in the report include De Soutter Medical Ltd., Peter Brasseler Holdings, LLC, Intrauma S.p.A., GEISTER Medizintechnik GmbH, and Ruijin Medical Instrument & Device Co., Ltd.

Click Here: 

https://www.alliedmarketresearch.com/powered-surgical-instrument-market

]]>
rise in incidence of different forms of cancer and increase in adoption of cancer pain drugs Thu, 25 Feb 2021 11:35:10 +0100 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_modena/691571.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_modena/691571.html Automotive Market Research Reports Automotive Market Research Reports  The growth of the pain management devices market is attributed to increase in prevalence of chronic pain across the globe. Furthermore, surge in awareness of pain management devices, launch of innovative products, and rise in adoption of pain management devices are the other factors that contribute to the growth of the market.

Rise in prevalence of chronic disease, surge in geriatric population, and increase in adoption of pain management devices drive the growth of the global pain management devices market. However, preferable use of medications for pain management hampers the market growth. On the contrary, growth opportunities in emerging markets are expected to create lucrative opportunities in the industry.

The global pain management devices market size was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, growing at a CAGR of 6.7% from 2019 to 2026.

Image for post

Based on application, the cancer pain segment is expected to register the fastest CAGR of 8.3% during the forecast period. This is attributed to rise in incidence of different forms of cancer and increase in adoption of cancer pain drugs. In addition, upsurge in geriatric population and wide availability of pain management devices drive the market growth. However, the neuropathic pain segment dominated the global pain management devices market in 2018, accounting for nearly one-third of the market. The increase in number of target population, rise in number of risk factors such as diabetes, HIV, multiple sclerosis, & cancer, technological advancement in pain management devices, and surge in demand for pain management devices for management of neuropathic pain are driving the growth of the segment.

Key Findings of the Study:

  • By product, the neuromodulation & neurostimulation devices segment held more than half share in the global market in 2018.
  • Depending on application, the neuropathic pain segment held more than one-third share in the global market in 2018.
  • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.6% during the forecast period.

Leading market players analyzed in market such as Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Medtronic Plc., Pfizer, Inc., and Stryker Corp.

Click Here @ 

https://www.alliedmarketresearch.com/pain-management-devices-market

]]>
Bone Grafts and Substitutes Market is expected to reach $3,912 million by 2025 Wed, 24 Feb 2021 11:16:32 +0100 http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/691303.html http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/691303.html Automotive Market Research Reports Automotive Market Research Reports Rapid development of novel bone grafts materials such as biocompatible synthetic bone grafts and rise in prevalence of bone and joint disorders are the major factors driving the growth of the global bone grafts and substitutes market. Moreover, surge in the number of patients suffering from rheumatoid arthritis, osteoarthritis, and other joint disorders have supplemented the market growth. However, high cost of surgeries and several ethical issues associated with bone grafting procedures have hampered the market development. On the contrary, increasing inclination of key market players toward R&D activities and surge in demand for orthopedic procedures among geriatric population would provide lucrative opportunities for the market leaders in the coming years.

Bone Grafts and Substitutes Market, by Product and Application: Global Opportunity Analysis and Industry Forecast, 2018–2025,” the market was valued at $2,690 million in 2017, and is expected to reach $3,912 million by 2025, growing at a CAGR of 4.8% from 2018 to 2025.

Image for post

Bone grafts are implantable materials that promote bone healing, bone formation, and osseous reconstruction.

Major applications of bone grafts and substitutes

The report offers an in-depth analysis of the various applications of bone grafts and substitutes, including spinal fusion, trauma, joint reconstruction, dental bone grafting, and craniomaxillofacial. The spinal fusion segment dominated the global bone grafts and substitutes market in 2017 and is expected to hold the largest share in the global market through 2025, contributing about 45%. However, the joint reconstruction segment would witness the fastest CAGR of 6.2% through 2025, owing to rise in demand for joint reconstruction among patients suffering from rheumatoid arthritis, osteoarthritis, and other joint disorders.

Key Findings of the Bone Grafts and Substitutes Market:

  • Bone graft substitutes segment dominated the overall market with a share of more than half of the overall market in 2017, and is expected to continue to lead the during the forecast period.
  • Asia-Pacific is expected to witness highest market growth rate, with a CAGR of 7.3% from 2018–2025
  • U.S. accounted for more than half of the overall market in 2017, whereas South Korea is expected to register the highest CAGR of 9.7%.

Key market players

The leading companies in the global bone grafts and substitutes market include Medtronic plc, DePuySynthes, Wright Medical Group N.V., Xtant Medical Holdings, Inc. (Bacterin), Baxter International Inc., Stryker Corporation, Integra Lifesciences Holdings Corporation, Zimmer Biomet Holdings, Inc., Arthrex, Inc., and Musculoskeletal Transplant Foundation (MTF).

Read More: https://www.alliedmarketresearch.com/bone-graft-substitutes-market

]]>
The segment is expected to register the highest CAGR of 12.1% from 2020 to 2027 Wed, 24 Feb 2021 11:10:05 +0100 http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/691301.html http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/691301.html Automotive Market Research Reports Automotive Market Research Reports Surge in geriatric population, increase in incidences of diabetes, obesity and chronic conditions, and high-end technological advancements to deal with complex wounds fuel the growth of the global advanced wound care market. On the other hand, high cost of advanced wound care products impedes the growth to some extent. Nevertheless, untapped opportunities in developing economies is expected to create a number of opportunities for the key players in the industry.

The chronic wounds segment to remain lucrative during the estimated period-

Based on application, the chronic wounds segment contributed to more than two-thirds of the global advanced wound care market in 2018, and is anticipated to dominate during 2019–2026. The same segment is also projected to register the fastest CAGR of 6.7% by 2026. Various methods are now available to treat chronic wounds, including, debridement, moist wound healing, vacuum-assisted closure, oxygenation, warming etc., which has driven the growth of the segment.

Based on application, the chronic wounds segment accounted for the largest share in 2019, holding more than two-thirds of the advanced wound care market, and is expected to maintain the largest share throughout the forecast period. In addition, the segment is expected to register the highest CAGR of 12.1% from 2020 to 2027. The studies also includes acute wound segment.

“Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound Care, and Therapy Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Health Service Centers): Global Opportunity Analysis and Industry Forecast, 2019–2026.”

Global advanced wound care industry was estimated at $8.45 billion in 2018 and is expected to reach $13.94 billion by 2026, growing at a CAGR of 6.5% from 2019 to 2026.

Image for post

The chronic wounds segment to remain lucrative during the estimated period-

Based on application, the chronic wounds segment contributed to more than two-thirds of the global advanced wound care market in 2018, and is anticipated to dominate during 2019–2026. The same segment is also projected to register the fastest CAGR of 6.7% by 2026. Various methods are now available to treat chronic wounds, including, debridement, moist wound healing, vacuum-assisted closure, oxygenation, warming etc., which has driven the growth of the segment.

North America to maintain its dominance throughout the forecast period-

Based on geography, North America held the major share in 2018, generating nearly two-fifths of the global advanced wound care market. Development of advanced systems, upsurge in adoption of wound care products for the treatment of chronic & acute wounds, increase in incidence of chronic diseases, and surge in geriatric population have boosted the market in the province. The region across Asia-Pacific, on the other hand, would cite the fastest CAGR of 8.4% throughout the estimated period. Development in healthcare infrastructure, rise in number of laboratories with advanced medical facilities, and increase in number of target population in emerging economies have propelled the

Key market players

  • Adynxx, Inc.
  • 3M (Acelity Inc.)
  • Smith & Nephew Plc.
  • Coloplast A/S
  • ConvaTec Group Plc.
  • AB (Mölnlycke Health Care AB)
  • Essity AB (BSN Medical GmbH)
  • Medtronic Plc.
  • Integra Lifesciences (Derma sciences)
  • Investor Johnson & Johnson
  • Medline Industries, Inc.
  • B Braun Melsungen AG
  • Organogenesis Holdings Inc.

Click Here: https://www.alliedmarketresearch.com/Advanced-Wound-Care-marketLisa

]]>
Operating Room Management Market Research Report 2021 - 2027 Tue, 09 Feb 2021 12:12:33 +0100 http://comunicati.net/comunicati/aziende/trasporti/688226.html http://comunicati.net/comunicati/aziende/trasporti/688226.html Automotive Market Research Reports Automotive Market Research Reports Rise in incidences of chronic diseases, loss of patent extensions of branded drugs, and the increased availability of advanced diagnostics is expected to boost the growth of Operating Room Management Market. In addition, growth in technology for the production of Operating Room Management Market is projected to fuel the market growth.

Thus, it is imperative as well as strategic for hospitals to manage operating rooms efficiently as there is an opportunity to increase returns on investments by optimizing the use is greatest for operating rooms. 

Biologics Market Competitive Analysis:

Major players in the operating room management market host exhibition and seminars to display and promote the use of it in hospital industry. Some key players in the operating room management market are GE Healthcare, McKesson Corporation, Cerner Corporation Becton, Dickinson and Company, Surgical Information Systems, Optum, Meditech, Picis Clinical Solutions, Getinge AB and STERIS plc.

Operating room management market deals with long-term decision-making based on predicted work load which is not limited to maximizing the utilization of personnel’s and materials but it also involves expansion decisions, optimal patient safety and outcomes, decrease delays with an end result of achieving satisfaction of outcomes for both the physicians and the patients.

COVID-19 Scenario:

• Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

• However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

• Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

The market is analyzed based on regions and competitive landscape in each region is mentioned. Regions discussed in the study include North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). These insights help to devise strategies and create new opportunities to achieve exceptional results.

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
North America is expected to lead the market throughout 2022 and is projected to grow at a CAGR of 11.89%, during 2016 and 2022 Mon, 08 Feb 2021 12:17:12 +0100 http://comunicati.net/comunicati/hobby_e_tempo_libero/cucina/687994.html http://comunicati.net/comunicati/hobby_e_tempo_libero/cucina/687994.html Automotive Market Research Reports Automotive Market Research Reports Liver disease is characterized by improper functioning of liver, causing disorders like hepatitis, fatty liver, and cirrhosis. Some of the major drug categories used in the treatment of various types of liver diseases includes antirejecting drugs, vaccines, immunosuppressant, chemotherapy drugs and antiviral drugs.

Liver Disease Treatment Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $19,536 million by 2022, registering a CAGR of 11.72% during the period 2016 – 2022

Key findings of the study: 

  • Corticosteroids drug is projected to be the fastest growing segment, registering a CAGR of 16.49% during the forecast period
  • North America is expected to lead the market throughout 2022 and is projected to grow at a CAGR of 11.89%, during 2016 and 2022
  • Asia-Pacific is expected to grow with a CAGR of around 12.51%, due to increasing prevalence of liver diseases and increasing R&D investments in this region.

North America and Europe collectively accounted for more than two-fourth of the total liver disease treatment market in 2015, and are expected to maintain their position throughout the forecast period. This is due to the increasing prevalence of liver diseases, growing geriatric population, and increased awareness about the various liver diseases and their treatment in these regions. In addition, advancement in R&D is anticipated in the development of novel drug therapy for the treatment of liver diseases.

The prompt players in the liver disease treatment market have adopted strategies such as innovative product launch, merger & acquisition, partnership and business expansion to gain maximum market share. The major companies profiled in the report include, Gilead Science Inc., Bayer AG, AstraZeneca PLC, GlaxoSmithKline plc, Merck & Co. Inc, Sanofi AG , Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, and Johnson & Johnson Private Limited.

Growing geriatric population

Structural dysfunction or alteration due to aging mainly leads to liver diseases. According to the National Institute of Aging, geriatric population is likely to increase by 86% till 2050. 

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
North America held the largest share Thu, 04 Feb 2021 06:30:21 +0100 http://comunicati.net/comunicati/istituzioni/camere_di_commercio/687280.html http://comunicati.net/comunicati/istituzioni/camere_di_commercio/687280.html Automotive Market Research Reports Automotive Market Research Reports The growth of the psoriatic arthritis treatment market is attributed to rise in prevalence of psoriasis & psoriatic arthritis disease across the globe. Furthermore, surge in demand for novel treatments coupled with increase in number of pipeline drugs for psoriatic arthritis treatment is the major factors that contributes toward the growth of the global market.

The global psoriatic arthritis treatment market size was valued at $7,860 million in 2018, and is projected to reach $13,744 million by 2026, growing at a CAGR of 7.2% from 2019 to 2026.

Prime determinants for growing market

Rise in prevalence of psoriasis & psoriatic arthritis disease, increase in number of pipeline drugs, and surge in government expenditure on healthcare have boosted the growth of the global psoriatic arthritis treatment market. However, poor demand in under-developed countries hampers the market. On the contrary, growth potential in the emerging market is expected to create lucrative opportunities in the near future.

Psoriatic arthritis is a form of arthritis disorder developed in individuals affected by psoriasis. It leads to joint stiffness, pain, and swelling. Most individuals initially develop psoriasis and are later diagnosed with psoriatic arthritis. According to a study published by Celgene Corporation, in 2018, approximately 30% of patients with psoriasis disorder develop inflammatory situation involving joints, known as psoriatic arthritis. Several prescription and over-the-counter (OTC) drugs are available for the treatment of psoriatic arthritis. Some treat symptoms of both psoriatic arthritis and psoriasis, while others help with joint issues. Medications for psoriatic arthritis treatment include NSAIDs, DMARDs, biologics, and others.   

Prescription segment to manifest the fastest growth through 2026

The prescription segment is expected to manifest the fastest CAGR of 7.4% during the forecast period, owing to rise in demand for prescription drugs during the treatment of psoriatic arthritis without causing side effects. Moreover, the segment dominated the global psoriatic arthritis treatment market in 2018, accounting for more than four-fifths of the market. The report also analyzes the OTC segment.

Major market player

  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Eli Lilly And Company
  • Celgene Corporation
  • Merck & Co Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • UCB S.A.

Key Findings of the Study:

  • On the basis of drug type, the biologics segment held more than one-half share in the global market in 2018.
  • By type, the prescription drug segment accounted for the largest market share in 2018, and is expected to remain dominant throughout the forecast period. 
  • Depending on route of administration, the injectable segment held more than half share in the global market in 2018.
  • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.1% during the forecast period. 

North America held the largest share

The global psoriatic arthritis treatment market across North America held the largest share in 2018, contributing for more than half of the market, owing to presence of key players in the region. Moreover, rise in prevalence of psoriatic arthritis disease, surge in demand for psoriatic arthritis treatment drugs, presence of advanced healthcare facilities coupled with trained medical professionals, and surge in number of R&D centers significantly contribute toward the growth of the North America market. However, the Asia-Pacific segment is expected to register the fastest CAGR of 9.1% during the forecast period, owing to high population base, surge in awareness about psoriatic arthritis treatment products, and increase in prevalence of psoriasis & psoriatic arthritis disease in various countries.

Web:https://www.alliedmarketresearch.com  Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research
]]>
North America held the lion's share Thu, 04 Feb 2021 06:05:11 +0100 http://comunicati.net/comunicati/hobby_e_tempo_libero/cucina/687274.html http://comunicati.net/comunicati/hobby_e_tempo_libero/cucina/687274.html Automotive Market Research Reports Automotive Market Research Reports Rise in R&D investment and significant increase in cancer incidence across the globe have boosted the growth of the global healthcare CRO services market.

According to the report, the global healthcare CRO services market was pegged at $38.99 billion in 2018, and is projected to garner $66.03 billion by 2026, growing at a CAGR of 6.9% from 2019 to 2026.

CRO is an organization or a group that provides services including clinical trials and early phase development of drugs or a medical device other organizations or companies on a contract basis. These organizations provide support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. These organizations or companies contract CROs for conducting clinical trials to explicit the need of hiring permanent staff. Further, contracting with CROS effectively reduces the time it takes to conduct a trial in-house leading to significant cost savings. Several companies prefer such organizations to conduct research on behalf of them for cost savings.

The clinical research services segment dominated the market

Based on service type, the clinical research services segment held the largest share in 2018, accounting for more than two-fifths of the global healthcare CRO services market. Moreover, the segment is expected to reach 7.3% from 2019 to 2026, owing to remarkable rise in clinical trials and development of various drugs and novel molecules for the treatment of several diseases.

North America held the lion’s share

Based on geography, the market across North America held the largest share in 2018, contributing to nearly half of the total revenue, owing to rise in biotechnology and pharmaceutical research by industry giants in the region. However, the global healthcare CRO services market across Asia-Pacific is anticipated to manifest the fastest CAGR of 7.4% during the study period, due to rise in demand for healthcare CRO services.

Major market players

  • IQVIA
  • ICON
  • PRA Health Sciences
  • Evotec
  • Syneos
  • Medpace
  • Charles River
  • Labcorp
  • Syngene
  • Biotelemetry

Key Findings of the Study:

  • By service type, the clinical research services segment accounted for the highest healthcare CRO services market share of 40% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
  • By region, North America was the major shareholder and accounted for the highest share of 48% in 2018.
  • By therapeutic area, the oncology segment is expected to grow at a CAGR of 7.3% during the forecast period.

Web:https://www.alliedmarketresearch.com

Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-researc

]]>
The rising demand for quality fish, consumer preference shifting towards seafood chiefly as a source rich of protein Wed, 03 Feb 2021 11:55:07 +0100 http://comunicati.net/comunicati/hobby_e_tempo_libero/varie/687094.html http://comunicati.net/comunicati/hobby_e_tempo_libero/varie/687094.html Automotive Market Research Reports Automotive Market Research Reports The current scenario of aquaculture development is toward increased commercialization of aquatic production. Due to expansion of aquaculture activities, the likelihood of major disease problems occurring increases. The aquaculture industry is under constant threat due to problems caused by viruses, bacteria, fungi, parasites and other undiagnosed and emerging pathogens. Disease has now become a primary constraint to the culture of many aquatic species, affecting both economic and social development in many countries. 

Companies covered:

  • Zoetis
  • Archer Daniels Midland Company
  • Bayer Animal Health
  • Elanco
  • Virbac S.A.
  • Merck & Co. Inc.
  • Alltech
  • Benchmark Holdings Plc.

Top impacting factors: Market Scenario Analysis:

The rising demand for quality fish, consumer preference shifting towards seafood chiefly as a source rich of protein than any other animal based protein, increasing incidences of infections and diseases in farmed fishes has bolstered the need for seafood and is driving the aquaculture healthcare market. However, lack of knowledge regarding diseases in aquatic culture systems, misconceptions regarding farmed fish and product consumptions due to health concerns and issues over growing antibiotic resistance due to widespread use of immunostimulants are the factors limiting the growth of the aquaculture healthcare market.

COVID – 19 scenario analysis:  

  • Due to COVID-19 pandemic spread globally, many governments around the world are putting in place unprecedented lockdown measures in order to contain its impact on public health
  • Fish and other aquatic foods and products of aquaculture are a key part of food systems of major social, cultural and economic significance 
  • Disruptions in supply chains for fish and aquatic foods are taking place due to disruptions in transportation, trade, and labor. 
  • Delayed stocking of aquaculture systems and falling production from reduced fishing efforts will lead to lower supplies, access, and low consumption of these foods

Key benefits of the report:

  • This study presents the analytical depiction of the global aquaculture healthcare industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global aquaculture healthcare market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global aquaculture healthcare market growth scenario.

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
The development of human vaccines depends extensively on animal models by a large. Wed, 03 Feb 2021 11:46:43 +0100 http://comunicati.net/comunicati/istituzioni/comuni/marche/687090.html http://comunicati.net/comunicati/istituzioni/comuni/marche/687090.html Automotive Market Research Reports Automotive Market Research Reports Animal models have greatly improved the understanding of researchers related to the pathophysiology of various diseases like rheumatoid arthritis, systemic lupus erythematosus synovial hyperplasia, mononuclear cell infiltration, cartilage and bone erosions and many more have provided valuable insights for testing potential therapeutic treatment.

Top impacting factors: Market Scenario Analysis

Animal model have been extensively used in experimental research to enhance human understandings and find the solutions to complex biological and biomedical constraints and has been highly preferred as means of experiment by scientists and researchers. For cosmetic research and for testing different therapeutic treatments, animal models are commonly used. New drugs are tested first on animals for safety and efficacy and checking the side effects before they are examined for human use. Mere 5% of the drugs derived from animal models are suitable for humans which highlights the scope that exists with abundant opportunities for research and investment in the field. 

However, use of animal models being an expensive and time-consuming process, the strict regulations and guidelines while using animal models for research and the growing use of animals such as monkeys and dogs has raised concern among various animal welfare organizations and NGOs which has resulted in the research organizations to find new ways to reduce the number of animals in research. These factors have been limiting the growth of the animal model market.

Use of animal models for vaccine development

The development of human vaccines depends extensively on animal models by a large. Several regulatory authorities have a mandate for novel vaccine candidates to go through preclinical where testing is done primarily on animal models before being eligible for experimentation on human subjects. A noteworthy change regarding reduction and replacement of animals as models has been witnessed in the recent years with the advancements in computational biology and bioinformatics methodologies for developing novel vaccine candidates.

Key benefits of the report:

  • This study presents the analytical depiction of the global clinical workflow solutions stem industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global animal model market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global clinical workflow solutions market growth scenario.

Companies covered:

Charles River Laboratories International, Horizon Discovery, The Jackson Laboratory, Taconic Biosciences, GenOway S.A., Eurofins Scientific, Crown Bioscience Inc., Envigo, Transposagen Biopharmaceuticals Inc.

]]>
This rising demand for therapeutics in the market has accelerated the R&D activities in order to develop novel therapeutic drugs Wed, 27 Jan 2021 12:22:40 +0100 http://comunicati.net/comunicati/istituzioni/camere_di_commercio/685570.html http://comunicati.net/comunicati/istituzioni/camere_di_commercio/685570.html Automotive Market Research Reports Automotive Market Research Reports Biologics and pharmaceutical organizations are adopting practices that ensure the availability of the product in the market at a rapid pace. This strategic approach is helping them bolster their position in the global cancer cachexia market. 

Clinical trials in progress in oncology field have highlighted the multifactorial pathogenicity of cachexia. Understanding the mechanism of cancer cachexia has become crucial for the understanding of prognostic factors for cancer. Cachexia is often a permanent side effect of diseases like HIV and Cancer. 

Top impacting factors: Market Scenario Analysis:

Factors like increasing prevalence of cancer and cancer cachexia in patients, the demand for therapeutic treatment and drugs have increased all over. This rising demand for therapeutics in the market has accelerated the R&D activities in order to develop novel therapeutic drugs. This has led to creation of a strong product pipeline consisting various therapy products. These factors have been major reason for the growth of the market. In addition, increased awareness has regarding this syndrome and advancements related to treatment of cancer cachexia has also helped the market growth. 

On the contrary, lack of studies and research that could explain high efficacy of a specific treatment, making the progress in the cancer cachexia market has been considerably at slower pace. The manufacturers of cancer cachexia drugs are hesitant while investing in the market because of the stringent regulatory guideline which may restrict the long-term growth of this market.

North American region expected to dominate the Cancer Cachexia Market

The U.S. alone accounted for an estimated 1.8 million cancer patients and over 606,000 deaths in 2019 and this number is expected to grow with time.  American region is expected to grow due to factors like rising incidence of cancer patients and hence cancer cachexia as well with the presence of large number of drug manufacturers and key players in the market along with advancing paradigm of care for cancer patients that is supporting the growth in this region. As a result, this segment holds the largest market share.

COVID – 19 scenario analysis:

  • Due to the COVID – 19  outbreak, majority of healthcare, pharmaceutical and biotechnology organizations have concentrated on diagnostics kits, safety wearables (PPE kits, face shields, masks) and treatment therapies and medication against Novel coronavirus
  • R&D labs are also focusing on finding a breakthrough vaccine against novel coronavirus
  • In addition, the medical professionals are engaged in providing COVID-19 related services, as a result, other healthcare segments  have to face negligence.

Companies covered:

Eterna Zentaris, Alder BioPharmaceuticals Inc., Eli Lilly and Company, GTx Inc., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, XBiotech, Inc., Pernix Therapeutics, Pfizer Inc, and Purdue Pharma L.P., Sanofi, SkyePharma, Takeda Pharmaceutical Company.

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
Existing cancer treatment studies have mostly been developed carried on animal based models, where therapies able to promote tumor shrinkage were seen effective Mon, 25 Jan 2021 12:00:26 +0100 http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/685203.html http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/685203.html Automotive Market Research Reports Automotive Market Research Reports The fatality rate of cancer has been on a rise globally. Hence various major players in cancer stem cells are investing money and funding associated R&D activity to get a breakthrough for treatment of cancer. Existing cancer treatment studies have mostly been developed carried on animal based models, where therapies able to promote tumor shrinkage were seen effective. However, animals do not provide a complete model of progression and mechanism of human disease.

The clinical relevance of CSCs has been proven by emerging evidence, explaining that CSCs are resistant to conventional radiation treatment and chemotherapy. They are believed to be an important target for novel anti-cancer drug discovery, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

Top impacting factors: Market Scenario Analysis:

Pouring of funds into R&D activities and government initiatives to boost research related to cancer, successful ventures in clinical oncology, improved survival rate of patients, and increase in transplantation procedures are considered as major factors responsible for fueling growth in the cancer stem cell market. On the contrary, inequality issues coupled with diagnosis and expensive cell therapy treatments through stem cell treatment is significantly hampering the growth of cancer stem cells market. High cost cell therapies & stringent regulations reducing market growth. 

Rising prevalence of cancer and increasing number of patients

According to the Cancer Research UK, around 17 million cancer cases were registered in 2018, out of which 56% of the cases were fatal. There are many key factors that may affect the success rate of chemo and radiation therapy and a person’s survival rate such as age, overall health and cancer stage. As per a research report by the World Health Organization (WHO), in low- and middle-income countries, around 70% of deaths occurs due to cancer. 

Companies covered:

Merck KGaA, Bionomics,Thermo Fisher Scientific Inc., AbbVie Inc., Lonza Inc., Miltenyi Biotec, PromoCell GmbH, Stemline Therapeutics, MacroGenics, Inc., OncoMed Pharmaceuticals Inc.,STEMCELL Technologies Inc.,Irvine Scientificand BIOTIME Inc.

Key benefits of the report:

  • This study presents the analytical depiction of the global cancer stem cells industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Cancer stem cells market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global cancer stem cells market growth scenario.

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
Increasing demand for organic non-opioid compounds Wed, 20 Jan 2021 12:27:04 +0100 http://comunicati.net/comunicati/istituzioni/camere_di_commercio/684464.html http://comunicati.net/comunicati/istituzioni/camere_di_commercio/684464.html Automotive Market Research Reports Automotive Market Research Reports CBD hemp oil is a mixture of various chemical compounds which have clinical significance in treatment against a variety of diseases. It is extensively used in treatment of people suffering with neurological disorders. CBD hemp oil is also attributed to be effective against various health problems and ailments like cancer, anxiety and depression and has added advantages such as pain relief, boosting cognitive abilities, anti-inflammatory properties among others.

Presence of a compound called Delta-9 tetrahydrocannabinol in the oil, is proving significant as it has shown positive outcomes when applied in stress relief and maintaining the body’s general state of balance.

Companies covered:

  • Cannavest
  • Pharmahemp,
  • ENDOCA
  • BAFA Gmbh
  • Protect Pharma
  • Rakitovica
  • Biobloom Hemp
  • DragonflyCBD
  • MH medical hemp GmbH
  • Elixinol

Top impacting factors: Market Scenario Analysis:

Due to recent studies and subsequent research of various CBD substances brought to notice the importance of CBD hemp oil in medical industry. In 2017, the National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies. The ever rising prevalence of several infectious and chronic diseases like cancer, diabetes and arising health problems like depression, stress, lack of sleep and mental disturbance especially in the upcoming generation due to various factors like change in lifestyle is expected to boost the growth of CBD hemp oil market in coming years.

North America Emerges as the Largest Market for CBD Hemp Oil

Legalization of marijuana countries like the United States, increasing usage due to rising awareness of the health benefits of CBD Hemp oil, North American region is predicted to have immense growth with highest market share in the global market. The presence of industry players in the region is also having a promising impact on the market growth. Furthermore, the heavy funding for R&D activities and well-developed healthcare infrastructure are fueling the market growth for CBD hemp oil.

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
The National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies. Fri, 15 Jan 2021 10:59:44 +0100 http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/683713.html http://comunicati.net/comunicati/istituzioni/comuni/abruzzo/683713.html Automotive Market Research Reports Automotive Market Research Reports Top impacting factors: Market Scenario Analysis

The ever rising prevalence of several infectious and chronic diseases like cancer, diabetes and arising health problems like depression, stress, lack of sleep and mental disturbance especially in the upcoming generation due to various factors like change in lifestyle is expected to boost the growth of CBD hemp oil market in coming years. Further, the use of hemp oil in numerous forms like spray, tincture and vape especially in the developed and developing economies is one of the major causes that would help the CBD hemp oil market growth. Its wide range of application against diverse diseases and various health benefits related with it such as pain relief, reduction in anxiety and depression, proven benefits when used as a topical ointment for treating skin problems and neuroprotective attributes results in increasing demand for CBD hemp oil all over and is expected to drive the growth of the market.

Due to recent studies and subsequent research of various CBD substances brought to notice the importance of CBD hemp oil in medical industry. In 2017, the National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies.

Companies covered:

Cannavest, Pharmahemp, ENDOCA, BAFA Gmbh, Protect Pharma, Rakitovica, Biobloom Hemp, DragonflyCBD, MH medical hemp GmbH, Elixinol.

According to a report published by World Health Organization, CBD shows no significant results indicative of any abuse or dependence potential. As of now, there is no significant evidence of side effects associated with the use of CBD. Presence of a compound called Delta-9 tetrahydrocannabinol in the oil, is proving significant as it has shown positive outcomes when applied in stress relief and maintaining the body’s general state of balance.

Geographies covered:

  • North America (U.S., Canada, Mexico)
  • Europe (France, Germany, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

However, prohibition for the use of CBD in some countries, the strict regulations regarding use of CBD hemp oil, complex administrative formation for the acceptance of hemp on a large scale and the scarcity of procurement of seeds for agricultural utilization of hemp are some circumstances which can restrain the growth of CBD hemp oil market. In order to overcome these hindrances, the key players in the market are coming up with various innovative solutions and the implementation of these solutions in the current industry scenario along with expansion policies in potential markets in the Asian region can be an important opportunity to grow the CBD hemp oil market.

Key benefits of the report:

  • This study presents the analytical depiction of the global CBD hemp oil industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global CBD hemp oil market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global CBD hemp oil market growth scenario.

North America Emerges as the Largest Market for CBD Hemp Oil

Legalization of marijuana countries like the United States, increasing usage due to rising awareness of the health benefits of CBD Hemp oil, North American region is predicted to have immense growth with highest market share in the global market. The presence of industry players in the region is also having a promising impact on the market growth. Furthermore, the heavy funding for R&D activities and well-developed healthcare infrastructure are fueling the market growth for CBD hemp oil.

]]>